Erbitux and the Press

Updated June 3, 2003 12:01 a.m. ET

The latest news on Erbitux, the ImClone cancer drug, is that it works just as well as the company claimed. There's a lesson here for everyone who pays attention to federal regulatory politics, especially for the press.